Drug Discovery and Development Centre (H3D), University of Cape Town

h3d.uct.ac.za

H3D is Africa’s first integrated drug discovery and development centre. The Centre is an accredited University of Cape Town research centre within the Faculty of Science but with strong affiliations with the Faculty of Health Sciences and specifically the Division of Pharmacology and the Institute for Infectious Diseases and Molecular Medicine (IDM). H3D operates within UCT’s world-class translational medicine research environment.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BUSINESS INSIGHTS

QUOTIENT SCIENCES ACQUIRES ARCINOVA

Quotient Sciences, Arcinova | February 09, 2021

news image

Quotient Sciences, the drug development and manufacturing accelerator, reported that it has procured Arcinova, the U.K.- based multiservice contract development and manufacturing organization (CDMO). With more than 40 years of involvement and 160 representatives, Arcinova gives drug substance, drug item and bioanalysis administrations to more than 200 pharma and biotech clients around the world. The obtaining expands Quotient's administration portfolio and will empower the inc...

Read More

CLARUS EQUIPS TOP PHARMACEUTICAL COMPANY, ASTRAZENECA, WITH INNOVATIVE THERMOBILE BOARDS IN THE FIGHT AGAINST COVID-19

Clarus | April 22, 2020

news image

Clarus, the industry leader in glassboard innovation and creator of the new TherMobile, a non-porous mobile board that serves as a protective shield during the health screening process, is successfully supporting AstraZeneca's efforts in keeping their essential employees safe while continuing to work during the COVID-19 crisis. "We initially developed TherMobile as a way to keep our own employees safe while implementing employee temperature screening at our facility," said Marc Man...

Read More

BUSINESS INSIGHTS

QHP CAPITAL ACQUIRES LEXITAS PHARMA SERVICES

Lexitas and QHP Capital | July 08, 2022

news image

QHP Capital the management company for NovaQuest Private Equity announced its acquisition of Lexitas Pharma Services a full-service ophthalmology contract research organization supporting biopharmaceutical and medical device clinical trials. Since 2011, Lexitas has provided clinical trial and medical strategy solutions to biopharmaceutical and medical device companies developing ophthalmic products. The Company provides end-to-end support and development expertise in the ant...

Read More

BUSINESS INSIGHTS

BASETWO LAUNCHES NO-CODE ARTIFICIAL INTELLIGENCE PLATFORM FOR PHARMACEUTICAL MANUFACTURING, RAISES $3.8 MILLION

Basetwo | May 27, 2022

news image

Basetwo, a SaaS AI platform for manufacturers, announced it secured a $3.8M seed round led by Glasswing Ventures and Argon Ventures with additional funding from Caffeinated Capital, Graphite Ventures, MaRs IAF, Pareto Holdings, Plug and Play, and Quiet Capital. The funding supports the launch of the category-making Basetwo AI platform, a first-of-its-kind solution that enables process engineers to rapidly build digital twins of their manufacturing plants leveraging a familiar no-c...

Read More
news image

BUSINESS INSIGHTS

QUOTIENT SCIENCES ACQUIRES ARCINOVA

Quotient Sciences, Arcinova | February 09, 2021

Quotient Sciences, the drug development and manufacturing accelerator, reported that it has procured Arcinova, the U.K.- based multiservice contract development and manufacturing organization (CDMO). With more than 40 years of involvement and 160 representatives, Arcinova gives drug substance, drug item and bioanalysis administrations to more than 200 pharma and biotech clients around the world. The obtaining expands Quotient's administration portfolio and will empower the inc...

Read More
news image

CLARUS EQUIPS TOP PHARMACEUTICAL COMPANY, ASTRAZENECA, WITH INNOVATIVE THERMOBILE BOARDS IN THE FIGHT AGAINST COVID-19

Clarus | April 22, 2020

Clarus, the industry leader in glassboard innovation and creator of the new TherMobile, a non-porous mobile board that serves as a protective shield during the health screening process, is successfully supporting AstraZeneca's efforts in keeping their essential employees safe while continuing to work during the COVID-19 crisis. "We initially developed TherMobile as a way to keep our own employees safe while implementing employee temperature screening at our facility," said Marc Man...

Read More
news image

BUSINESS INSIGHTS

QHP CAPITAL ACQUIRES LEXITAS PHARMA SERVICES

Lexitas and QHP Capital | July 08, 2022

QHP Capital the management company for NovaQuest Private Equity announced its acquisition of Lexitas Pharma Services a full-service ophthalmology contract research organization supporting biopharmaceutical and medical device clinical trials. Since 2011, Lexitas has provided clinical trial and medical strategy solutions to biopharmaceutical and medical device companies developing ophthalmic products. The Company provides end-to-end support and development expertise in the ant...

Read More
news image

BUSINESS INSIGHTS

BASETWO LAUNCHES NO-CODE ARTIFICIAL INTELLIGENCE PLATFORM FOR PHARMACEUTICAL MANUFACTURING, RAISES $3.8 MILLION

Basetwo | May 27, 2022

Basetwo, a SaaS AI platform for manufacturers, announced it secured a $3.8M seed round led by Glasswing Ventures and Argon Ventures with additional funding from Caffeinated Capital, Graphite Ventures, MaRs IAF, Pareto Holdings, Plug and Play, and Quiet Capital. The funding supports the launch of the category-making Basetwo AI platform, a first-of-its-kind solution that enables process engineers to rapidly build digital twins of their manufacturing plants leveraging a familiar no-c...

Read More